-+ 0.00%
-+ 0.00%
-+ 0.00%

Karyopharm Therapeutics sells 1,030,354 shares at $6.785; gross proceeds rise to about $30 million in RA Capital private placement

Reuters·03/27/2026 12:05:30

Please log in to view news